Evidence map›Paper›PMID 32838074›Full record

ArticleJACC. Basic to translational science2020

Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium.

Michael R Bristow, Lawrence S Zisman, Natasha L Altman, Edward M Gilbert, Brian D Lowes, Wayne A Minobe, Dobromir Slavov, Jessica A Schwisow, Erin M Rodriguez, Ian A Carroll and 3 more

Open access · goldAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Arrhythmia and COVID-19 in children.Clinical and experimental pediatrics · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Polygoni multiflori radix extracts inhibit SARS-CoV-2 pseudovirus entry in HEK293T cells and zebrafish larvae.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. COVID-lateral damage: cardiovascular manifestations of SARS-CoV-2 infection.Translational research : the journal of laboratory and clinical medicine · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Michael R BristowDivision of Cardiology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, Colorado.
Lawrence S ZismanGossamer Bio, San Diego, California.
Natasha L AltmanDivision of Cardiology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, Colorado.
Edward M GilbertDivision of Cardiology, University of Utah Medical Center, Salt Lake City, Utah.
Brian D LowesDivision of Cardiology, University of Nebraska Medical Center, Omaha, Nebraska.
Wayne A MinobeDivision of Cardiology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, Colorado.
Dobromir SlavovDivision of Cardiology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, Colorado.
Jessica A SchwisowDivision of Cardiology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, Colorado.
Erin M RodriguezDivision of Cardiology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, Colorado.
Ian A CarrollDivision of Cardiology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, Colorado.
Thomas A KeuerARCA Biopharma, Westminster, Colorado.
Peter M ButtrickDivision of Cardiology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, Colorado.
David P KaoDivision of Cardiology, University of Colorado, Denver/Anschutz Medical Campus, Aurora, Colorado.
University of Colorado Denver · USUniversity of Colorado Anschutz Medical Campus · USARCA Biopharma (United States) · USGossamer Bio (United States) · USUniversity of Nebraska Medical Center · USUniversity of Utah · US

Funding

Genetic-Adrenergic Interactions in Myocardial FailureR01HL048013 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BRISTOW, MICHAEL R. · 1993 to 2007
$4.5M
A Closed-Loop Integrated Framework for development of Novel Treatment Strategies in Heart Failure (CLIFFNOTES-HF)K08HL125725 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI KAO, DAVID PETER · 2017 to 2021
$826k
Gene expression profiles in the failing human heartK23HL068875 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI LOWES, BRIAN D · 2003 to 2007
$653k
Dynamic Expression Profiling in the Intact Human HeartR01HL071118 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BRISTOW, MICHAEL R. · 2002 to 2003
$304k
NHLBI NIH HHS K08 HL125725NHLBI NIH HHS K23 HL068875NHLBI NIH HHS R01 HL048013NHLBI NIH HHS R01 HL071118
6 · The paper itself

Abstract

Using serial analysis of myocardial gene expression employing endomyocardial biopsy starting material in a dilated cardiomyopathy cohort, we show that mRNA expression of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) cardiac myocyte receptor ACE2 is up-regulated with remodeling and with reverse remodeling down-regulates into the normal range. The proteases responsible for virus-cell membrane fusion were expressed but not regulated with remodeling. In addition, a new candidate for SARS-CoV-2 cell binding and entry was identified, the integrin encoded by

Indexed as

ACE2, angiotensin converting enzyme 2ACE, angiotensin converting enzymeangiotensin converting enzyme 2ARB, angiotensin receptor blockerBNP, B-type natriuretic peptidecoronavirus disease 2019COVID-19, coronavirus disease-2019EmBx, endomyocardial biopsiesF/NDC, nonischemic dilated cardiomyopathy with heart failureHFrEF, heart failure with reduced (<0.50) left ventricular ejection fractionintegrinsIQR, interquartile rangeLOCF, last observation carried forwardLVEF, left ventricular ejection fractionLV, left ventricle (ventricular)mRNA, messenger ribonucleic acidNF, nonfailingNR, nonresponderPCR, polymerase chain reactionproteasesRAS, renin-angiotensin systemRGD, arginine-glycine-aspartic acidRNA-Seq, ribonucleic acid sequencingR, responderRV, right ventricle (ventricular)SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2ventricular remodeling

Identifiers

PMID32838074
PMCPMC7314447
OpenAlexW3036207734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.